UK pharmacists gain powers to address drug shortages

INICIO/Políticas y legislación | Posted 22/02/2019 post-comment0 Post your comment

Pharmacists in the UK are gaining news powers to be able to dispense alternatives when there are drug shortages.

Drug shortages 3 V13k14

The Human Medicines (Amendment) Regulations 2019, which came into force on 9 February 2019, includes provisions that allow pharmacies to dispense an alternative under a ‘serious shortage protocol’ where there is or may be a serious shortage of particular prescription-only medicines. This means that, when the protocol is implemented, pharmacists can substitute a different strength, quantity or pharmaceutical form of a prescription-only medicine, or a different prescription-only medicine or a generic equivalent, according to the protocol rather than the prescription, and without going back to the prescriber.

An explanatory note was published by the UK’s drug regulator, the Medicines and Healthcare products Regulatory Agency. In the note, the agency said that the new powers for pharmacists ‘do not relate to withdrawal from the European Union (EU)’. However, if the withdrawal affects medicines supplies, a ‘serious shortage protocol’ could be used in those circumstances. However, on 17 January 2019, England’s Chief Pharmaceutical Officer Keith Ridge said in a letter to National Health Service pharmacy leaders, that the ‘serious shortage protocols’ form part of ‘Government’s contingency preparations for a ‘no deal’ EU exit’.

Although the regulations came into force on 9 February 2019, pharmacies will have to wait for UK Ministers to publish a ‘serious shortage protocol’. This, according to the explanatory note, will only happen ‘when they consider that a medicine is or may become in serious shortage’.

A standard template for the protocols will be developed and any necessary protocols would be issued and kept centrally. Any alternative quantity, strength, pharmaceutical form or medicine which is to be supplied would also be agreed centrally and would be based on the views of senior clinical advisors.

A survey carried out by the All-Party Pharmacy Group in 2016 found that 56% of pharmacists and 37% of doctors were ‘almost certain’ to be out of stock of a medicine or prescribe a medicine once a day over the last six months. The UK’s Department of Health, however, responded that the ‘vast majority’ of prescriptions in the country are not subject to supply problems [1].

Related article
UK introduces new law to control generic drug prices

Reference
1. GaBI Online - Generics and Biosimilars Initiative. UK’s DoH says most medicines do not experience shortages [www.gabionline.net]. Mol, Belgium: Pro Pharma Communications International; [cited 2019 Feb 22]. Available from: www.gabionline.net/Pharma-News/UK-s-DoH-says-most-medicines-do-not-experience-shortages

Permission granted to reproduce for personal and non-commercial use only. All other reproduction, copy or reprinting of all or part of any ‘Content’ found on this website is strictly prohibited without the prior consent of the publisher. Contact the publisher to obtain permission before redistributing.

Copyright – Unless otherwise stated all contents of this website are © 2019 Pro Pharma Communications International. All Rights Reserved.

Source: Legislation.gov, NHS

comment icon Comments (0)
Post your comment
Related content
Nomenclatura de biológicos y biosimilares en Perú
02 AA010638
INICIO/Políticas y legislación Posted 20/05/2022
Nomenclatura de biológicos y biosimilares en Chile
22119008_l
INICIO/Políticas y legislación Posted 22/04/2022
Nomenclatura de biológicos y biosimilares en Colombia
Colombia V14I19
INICIO/Políticas y legislación Posted 08/04/2022
Nomenclatura de biológicos y biocomparables en México
Naming 3 V13J04
INICIO/Políticas y legislación Posted 18/03/2022
Most viewed articles
Sobre GaBI
INICIO/Sobre GaBI Posted 06/08/2009
EU guidelines for biosimilars
EMA logo 1 V13C15
INICIO/Directrices Posted 08/10/2010